NHD Global
Source-traceable research summaries
Structured readings of published human, animal and regulatory evidence. Each page reports the study design, exact result, limitations and the boundary between a public study intervention and a catalog material.
Randomized controlled human trial · Phase 2
Adults with obesity or overweight plus a weight-related condition
A source-traceable reading of the randomized Phase 2 obesity trial, including the dose-group results, adverse-event pattern and the limits of applying a clinical intervention record to research material.
Randomized controlled human trial · Phase 3
Adults with obesity or overweight, without diabetes
A structured reading of the SURMOUNT-1 Phase 3 trial, preserving the randomized design, four-group results, discontinuation data and the distinction between an approved finished drug and research-use material.
Randomized human PK/PD evidence · early phase
Healthy adult human pharmacokinetic/pharmacodynamic study
A close reading of the two randomized ascending-dose studies in healthy adults, focusing on GH and IGF-I time courses, estimated half-life and why the findings do not apply to CJC-1295 without DAC.
Randomized preclinical animal evidence
Rat Achilles tendon transection-and-repair model
A preclinical evidence case covering the four randomized rat groups, the split biomechanical and histology samples, statistically significant findings and the absence of an added combination benefit.
How to read this library
Tell us what you need. Your enquiry will be routed to the appropriate contact for catalog numbers, availability and quotation details.
